A US private equity firm has taken control of NHS patient records in a $400m deal, raising urgent concerns about data privacy and patient care. This transfer of sensitive health data to TPG, the investment firm behind Optum UK, has been met with alarm from doctors, MPs, and human rights groups.
How Private Equity Now Owns NHS Data Infrastructure
The acquisition of Optum UK gives TPG control over the electronic patient record system used by most GP practices in England. This system holds the medical histories of more than half the country's population. The Doctors' Association UK (DAUK) warns that private equity now owns the plumbing of English general practice.
Get the #1 Wireless Door Camera
REOLINK Bestseller: 2K Weatherproof Video Doorbell, No Monthly Fees.
Alarming Precedents: Palantir and TPG's Track Record
This is not the first time NHS data has been handed to a US tech firm. The earlier Palantir deal faced similar backlash. However, TPG's history in other countries adds a new layer of concern. Hospitals linked to TPG in Africa have been accused of pushing patients into debt through excessive medical bills, as investigated by the International Consortium of Investigative Journalists.
| Concern | Details |
|---|---|
| Patient Data Control | Private equity now controls the electronic records of over 30 million NHS patients. |
| Lack of Scrutiny | The deal was rubber-stamped without parliamentary debate or public consultation. |
| Risk of Data Sale | No safeguards exist if TPG later sells the asset to another private company. |
| Patient Privacy | Sensitive health data could be used for profit, not patient care. |
Key Takeaways for Patients and Policymakers
- Data sovereignty: NHS patient records are now under the control of a foreign private equity firm.
- Profit vs. care: TPG’s business model prioritizes investor returns over patient welfare.
- Lack of transparency: The deal was completed without public input or parliamentary approval.
- Future risks: If TPG sells the data asset, there are no clear protections for patient privacy.
What the Critics Say
Helen Morgan, Liberal Democrats’ health spokesperson, stated that such deals are being rubber-stamped without any scrutiny or protections for patients. She urged the government to start backing British tech instead of handing over sensitive data to US firms. The campaign group DAUK called for the government to set out what safeguards exist and what will happen to the data if the asset is sold.
FAQ
Why are NHS patient records being transferred to a US private equity firm?
The investment firm TPG bought Optum UK, the company behind the electronic patient record system used by most GP practices in England. The deal was valued at about $400m and gives TPG control over millions of sensitive health records.
What are the risks of private equity controlling NHS data?
Critics warn that private equity prioritizes profits over patient care. There are also concerns about data privacy, potential sale of patient records, and lack of public oversight. TPG's track record in Africa includes accusations of pushing patients into debt.
Can the government intervene to protect patient data?
MPs and campaign groups are calling for the government to set out safeguards, including what happens to the data if TPG later sells the asset. Currently, there has been no parliamentary debate or public consultation on the deal.
How does this compare to the earlier Palantir deal?
Both involve US tech firms gaining access to NHS data. However, Palantir's involvement was more focused on data analytics, while TPG now controls the core patient record system. The difference, according to DAUK, is that this time a private equity giant with a questionable track record is involved.
The public’s trust in the NHS is at stake. As this deal moves forward, it is essential to demand transparency, secure data protections, and a clear commitment to patient-first policies. Stay informed and advocate for your privacy rights.